Description

Human Mixtard (30/70) 40iu Injection is a medicine that contains Biphasic Isophane Insulin as its active ingredient. It is a mixture of two types of insulin – short-acting insulin and intermediate-acting insulin. This combination of insulin is designed to provide better blood sugar control throughout the day. Biphasic Isophane Insulin is used to treat diabetes mellitus, a condition characterized by high blood sugar levels. It helps regulate blood sugar by replacing the insulin that is normally produced in the body. Human Mixtard (30/70) 40iu Injection is typically prescribed for patients with diabetes who require insulin therapy to manage their blood glucose levels. The ratio of 30/70 indicates that 30% of the insulin is short-acting and 70% is intermediate-acting, providing a balance between immediate blood sugar control and sustained effect.

Additional information